Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis
Simvastatin treatment in a baboon endometriosis model decreased miR-150-5p and miR-451a and increased miR-3613-5p levels, normalizing them towards control expression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study evaluated whether previously identified circulating serum microRNAs that are dysregulated in human endometriosis could be measured in a nonhuman primate model and whether they change with simvastatin treatment. Endometriosis was induced in 16 baboons, randomized to simvastatin or vehicle for 90 days, and serum levels of 9 target miRNAs were quantified by qRT-PCR after 3 months; the paper reports that miR-150-5p and miR-451a decreased, while miR-3613-5p increased in simvastatin-treated animals compared with untreated endometriosis, and that these patterns paralleled human findings and returned toward control-like expression. A key caveat is that this was a pilot study with a limited sample size and focused on a predefined miRNA panel rather than a broader discovery approach. This paper is centrally about endometriosis — it uses a baboon endometriosis model to test serum microRNA biomarkers and how simvastatin alters their expression.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (67)
- A polymorphism in a let‐7 microRNA binding site of KRAS in women with endometriosis via openalex
- Aromatase inhibitor regulates let-7 expression and let-7f–induced cell migration in endometrial cells from women with endometriosis via openalex
- Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons via openalex
- Atorvastatin causes regression of endometriotic implants in a rat model via openalex
- Cellular Changes Consistent With Epithelial–Mesenchymal Transition and Fibroblast-to-Myofibroblast Transdifferentiation in the Progression of Experimental Endometriosis in Baboons via openalex
- Challenges in endometriosis miRNA studies — From tissue heterogeneity to disease specific miRNAs via openalex
- Circulating microRNAs as potential biomarkers for endometriosis via openalex
- Circulating MicroRNAs Identified in a Genome-Wide Serum MicroRNA Expression Analysis as Noninvasive Biomarkers for Endometriosis via openalex
- c-Jun NH2-terminal kinase inhibitor bentamapimod reduces induced endometriosis in baboons: an assessor-blind placebo-controlled randomized study via openalex
- Clinical relevance of the baboon as a model for the study of endometriosis via openalex
- Contribution of Bone Marrow-Derived Stem Cells to Endometrium and Endometriosis via openalex
- Effect of simvastatin on baboon endometriosis† via openalex
- Effects of Simvastatin on Retinoic Acid System in Primary Human Endometrial Stromal Cells and in a Chimeric Model of Human Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and Infertility via openalex
- Evaluation and treatment of endometriosis. via openalex
- High-dose atorvastatin causes regression of endometriotic implants: a rat model via openalex
- In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells via openalex
- MicroRNA 135 Regulates HOXA10 Expression in Endometriosis via openalex
- MicroRNAs and Endometriosis: Distinguishing Drivers from Passengers in Disease Pathogenesis via openalex
- Nonhuman Primate Models for Translational Research in Endometriosis via openalex
- Novel Therapies Targeting Endometriosis via openalex
- Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis via openalex
- Progesterone resistance in endometriosis is modulated by the altered expression of microRNA-29c and FKBP4 via openalex
- Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis via openalex
- Serum miR-451a Levels Are Significantly Elevated in Women With Endometriosis and Recapitulated in Baboons (Papio anubis) With Experimentally-Induced Disease via openalex
- Simvastatin Decreases Invasiveness of Human Endometrial Stromal Cells1 via openalex
- Simvastatin Induces Apoptosis and Alters Cytoskeleton in Endometrial Stromal Cells via openalex
- Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis via openalex
- Simvastatin Protects against the Development of Endometriosis in a Nude Mouse Model via openalex
- Statins Inhibit Growth of Human Endometrial Stromal Cells Independently of Cholesterol Availability1 via openalex
- Statins Inhibit Monocyte Chemotactic Protein 1 Expression in Endometriosis via openalex
- Stem cells in endometrium and their role in the pathogenesis of endometriosis via openalex
- Systemic Inflammation Induced by microRNAs: Endometriosis-Derived Alterations in Circulating microRNA 125b-5p and Let-7b-5p Regulate Macrophage Cytokine Production via openalex
- The non-human primate model of endometriosis: research and implications for fecundity via openalex
- The Role of Stem Cells in the Etiology and Pathophysiology of Endometriosis via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- W2000750042 via openalex
- W2043278995 via openalex
- W1970970870 via openalex
- W1897695060 via openalex
- W1809124392 via openalex
- W1793251081 via openalex
- W2591729572 via openalex
- W2607147921 via openalex
- W2610204288 via openalex
- W1573672642 via openalex
- W2753109313 via openalex
- W2762684183 via openalex
- W2766682049 via openalex
- W2767350841 via openalex
- W2781987324 via openalex
- W4211081176 via openalex
- W2306730192 via openalex
- W2066442082 via openalex
- W2101386379 via openalex
- W2111533160 via openalex
- W2115093090 via openalex
- W144423133 via openalex
- W2033820943 via openalex
- W2017571136 via openalex
- W2124756133 via openalex
- W2134528950 via openalex
- W2141138739 via openalex
- W2014946489 via openalex
- W2012258936 via openalex
- W2002356915 via openalex
Cited by (13)
- Identifying serum microRNAs as biomarkers for endometriosis in adolescents and young adults 2025
- Endometriosis: A Comprehensive and Concise Review of Potential Biomarkers and Treatment Therapies 2024
- Reflections on the complex mechanisms of endometriosis from the perspective of ferroptosis 2024
- The Known, the Unknown and the Future of the Pathophysiology of Endometriosis 2024
- Seven days of statin treatment improves nitric-oxide mediated endothelial-dependent cutaneous microvascular function in women with endometriosis 2022
- Knockdown of miR-150-5p reduces hypoxia-induced autophagy and epithelial-mesenchymal transition of endometriotic cells via regulating the PDCD4/NF-κB signaling pathway 2022
- A critical appraisal of the circulating levels of differentially expressed microRNA in endometriosis 2021
- WITHDRAWN: Endometriosis related sex steroid hormones, hypothalamic pituitary gonadal axis hormones and related animal modeling: A comprehensive review of published articles and endometriosis induction methods from 2010 to 2021 with scoring based approach 2021
- Accurate diagnosis of endometriosis using serum microRNAs 2020
- Role of Non-coding RNAs in the Pathogenesis of Endometriosis 2020
- MicroRNAs in endometriosis: biological function and emerging biomarker candidates† 2019
- Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis 2018
- Anti‐Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms 2018
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:55.107525+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00